Aion Therapeutic Inc. (ANTCF)
OTCMKTS · Delayed Price · Currency is USD
0.0017
+0.0004 (30.77%)
At close: Jul 31, 2025
Aion Therapeutic Market Cap
Aion Therapeutic has a market cap or net worth of $1.79 million as of August 22, 2025. Its market cap has decreased by -70.70% in one year.
Market Cap
1.79M
Enterprise Value
3.80M
Revenue
1.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 21, 2019, Aion Therapeutic's market cap has decreased from 6.75M to 1.79M, a decrease of -73.50%. That is a compound annual growth rate of -18.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 1.80M | -47.97% |
| Dec 31, 2024 | 3.46M | -44.60% |
| Dec 28, 2023 | 6.24M | 473.04% |
| Dec 30, 2022 | 1.09M | -61.15% |
| Dec 31, 2021 | 2.80M | -73.73% |
| Dec 31, 2020 | 10.66M | 487.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 385.65M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |